Home › Obesity › New Mexico › Albuquerque
Obesity clinical trials in Albuquerque, NM
7 studies for Obesity are looking for participants at sites in and around Albuquerque (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
RecruitingPhase 3
- Albuquerque Clinical Trials, Inc., Albuquerque
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RecruitingPhase 3
- Albuquerque Clinical Trials, Inc., Albuquerque
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
RecruitingPhase 3
- Albuquerque Clinical Trials, Inc., Albuquerque
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
RecruitingPhase 3
- The Sleep Spot - Maimonides, Albuquerque
Effect of Tirzepatide on Markers of MASLD in Patients With Obesity
RecruitingEarly phase 1
- University of New Mexico Health Sciences Center, Albuquerque
Ketogenic Diet and Diabetes Demonstration Project
RecruitingHealthy volunteers welcome
- University of New Mexico, Albuquerque
Uterine Preservation Via Lifestyle Transformation
RecruitingPhase 2
- University of New Mexico, Albuquerque
About Obesity
Read about the causes of obesity and find out what you can do to decrease your risk of its associated health issues.
More about Obesity on MedlinePlus
Obesity trials in other cities
- Houston, TX44 studies
- Chicago, IL42 studies
- New York City, NY40 studies
- San Antonio, TX39 studies
- Washington, DC33 studies
- Dallas, TX31 studies
- Orlando, FL29 studies
- Boston, MA28 studies
- Miami, FL27 studies
- Las Vegas, NV27 studies
- Atlanta, GA25 studies
- Jacksonville, FL25 studies
Other studies in Albuquerque
- Non-Small Cell Lung Cancer18 studies
- Breast Cancer17 studies
- Ovarian Cancer15 studies
- Cancer (all types)15 studies
- Lung Cancer14 studies
- Endometrial Cancer13 studies
- Metastatic Cancer12 studies
- Type 2 Diabetes11 studies
- Cardiovascular Disease10 studies
- Melanoma9 studies
- Prostate Cancer9 studies
- Acute Myeloid Leukemia9 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.